The largest database of trusted experimental protocols

Easysep biotin positive selection kit 2

Manufactured by STEMCELL

The EasySep Biotin Positive Selection Kit II is a laboratory equipment used for isolating specific cell types from a heterogeneous cell sample. It utilizes biotin-labeled antibodies and magnetic particles to select and enrich the target cells.

Automatically generated - may contain errors

2 protocols using easysep biotin positive selection kit 2

1

Isolation and Transfer of C5aR1+ Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood from T127 carrying FVB mice was collected through orbital sinus of isoflurane anesthetized mice. Blood was collected with EDTA blood collection microtubes. After serum aspiration, blood was diluted with PBS and put through density centrifugation with Ficoll. After carefully extracting the layer of the mononuclear cells, cells were washed three times with PBS. CD11b positive cells were isolated by EasySep Mouse CD11b positive selection Kit II (STEMCELL, 18970). The CD11b positive cell pool was incubated with primary C5aR1 antibody at 3 μg/ml in PBS with 2% FBS. Secondary antibodies conjugated with Biotin were added 1.2 μg/ml in PBS with 2% FBS. Magnetic column based cell sorting was performed by following manufacture’s manual of EasySep Biotin Positive Selection Kit II (STEMCELL, 17683). The purity of positive cells was assessed with flow cytometry. 5*105 C5aR1hi cells in 100 μl selection buffer or only 100 μl selection buffer was transferred to FVB mouse 2 weeks after T22 transplantation through tail vein injection. Olaparib treatment started on the second day after C5aR1hi cell transplantation with the same dose indicated above.
+ Open protocol
+ Expand
2

Quantifying Tumor-Specific T-Cell Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
MC38 tumors were subcutaneously injected on the right flank of C57BL/6 mice, and 20 μg of anti–CTLA-4×SIRPα or molar equivalents of anti–CTLA-4 plus SIRPα were intraperitoneally administrated on day 13. Five days after treatment, tumors and dLN were collected. Tumors were processed as described in the “Tissue homogenate preparation” section. Tumor-infiltrating immune cells were isolated by biotinylated anti-CD45 antibody and EasySep Biotin Positive Selection Kit II (STEMCELL) according to the manufacturer’s instructions. Irradiated MC38 tumor cells and control LLC tumor cells were used to restimulate tumor-specific T cells. A total of 1.5 × 105 dLN cells or 2 × 104 TILs and 7.5 × 104 irradiated tumor cells (40 grays) were cocultured for 48 hours, and enzyme-linked immunosorbent spot assay (ELISPOT) was performed using the IFN-γ ELISPOT kit (BD Biosciences) according to the manufacturer’s instructions. IFN-γ spots were enumerated with the CTL-ImmunoSpot S6 Analyzer (Cellular Technology Limited).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!